Utah

Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical

SALT LAKE CITY, March 25, 2020 /PRNewswire/ -- Elevar Therapeutics, Inc., a fast-growing biopharmaceutical company focused on promising therapies for unmet medical needs in cancer, announced today an agreement with Swedish-based…
Continue Reading »